1948-1990: Going global
The Boehringer Ingelheim history from 1948-1990, with milestones
Search
GPP Interview with Professor Barker
An interview with Prof. Barker about generalized pustular psoriasis, its burden on patients and how patient outcomes can be improved
Taking cancer on with smart combinations
Boehringer Ingelheim digs deep into the science and taking a precision approach to develop smart combinations to bring the greatest benefit to patients.
Disentangling fibrosis
Fibrosis is an important area of research for Boehringer Ingelheim that is focusing on fibrotic conditions of the liver, lung, kidney, skin and gut.
Effective vaccine against most virulent strains of Marek's disease affecting poultry
Effective vaccine against most virulent strains of Marek's disease affecting poultry launched in Egypt
Targeting Tumor Stroma
Boehringer Ingelheim’s research approach in stromal biology may lead to new medicines that will change the face of cancer and give new hope to patients
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Grass Roots Events 2022
View our list of Grass Roots events in 2022 and find an event near you.
Performance Indicators
Performance indicators concerning Environment Health and Safety (EHS) are summarized here.